Study Information
Status: Completed
Study Details
View study details on clinicaltrials.gov.
Locations
East Bay
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
Description
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Relapsing Forms of Multiple Sclerosis
Location: REDI (East Bay)
Principal Investigator
Recruitment Information
Contact 510.204.5571
Related Studies
Quantifying 2D and 3D MRI Imaging For Improving MS Diagnosis, Treatment, And Clinical Care
Create a longitudinal proof-of-concept MS research database (MSClinQ) that can support clinical queries, and can be updated with new tx, dx tools, care options
Investigators: Xiaowei (Sherry) Yan, PhD, MS, J.B. Jones, PhD, MBA
Using Mobile Technology and Analytics to Track Outcomes in MS Patients
Develop an app to collect and transform pt-reported outcomes in MS for health care providers to improve care and support shared decision making.
Investigators: Xiaowei (Sherry) Yan, PhD, MS, J.B. Jones, PhD, MBA
Precision Medicine for Multiple Sclerosis: Making It Work (MS-SHARE)
Develop an app that support access to clinical data and shared decision-making, predict disease course, and guide disease management.
Investigators: J.B. Jones, PhD, MBA, Xiaowei (Sherry) Yan, PhD, MS